{
    "eid": "2-s2.0-85109378312",
    "title": "Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET/CT using dual-tracer learning",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Deep learning",
        "miTNM",
        "PET/CT",
        "Prostate cancer",
        "PSMA",
        "Staging"
    ],
    "authors": [
        "Nicol\u00f2 Capobianco",
        "Ludovic Sibille",
        "Maythinee Chantadisai",
        "Andrei Gafita",
        "Thomas Langbein",
        "Guenther Platsch",
        "Esteban Lucas Solari",
        "Vijay Shah",
        "Bruce Spottiswoode",
        "Matthias Eiber",
        "Wolfgang A. Weber",
        "Nassir Navab",
        "Stephan G. Nekolla"
    ],
    "citedby-count": 12,
    "ref-count": 36,
    "ref-list": [
        "Cancer statistics, 2020",
        "Prostate cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology",
        "Current status of MRI and PET in the NCCN guidelines for prostate cancer",
        "Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study",
        "Diagnostic efficacy of68gallium-PSMA positron emission tomography compared to conventional imaging for lymph node Staging of 130 consecutive patients with intermediate to high risk prostate cancer",
        "Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy",
        "Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy",
        "68Ga-PSMA PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0",
        "Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging",
        "Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls",
        "Matched-pair comparison of68Ga-PSMA-11 PET/CT and18F-PSMA-1007 PET/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy",
        "68Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer",
        "18F-PSMA-1007 PET/CT detects micrometastases in a patient with biochemically recurrent prostate cancer",
        "Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT",
        "Proposal for a structured reporting system for prostate-specific membrane antigen\u2013targeted PET imaging: PSMA-RADS version 1.0",
        "E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET",
        "Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer",
        "Semiautomatically quantified tumor volume using68Ga-PSMA-11 PET as a biomarker for survival in patients with advanced prostate cancer",
        "68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer",
        "PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis",
        "Prostate cancer nodal staging: using deep learning to predict 68Ga-PSMA-positivity from CT imaging alone",
        "Exploring new multimodal quantitative imaging indices for the assessment of osseous tumor burden in prostate cancer using68Ga-PSMA PET/CT",
        "EBONI: a tool for automated quantification of bone metastasis load in PSMA PET/CT",
        "qPSMA: semiautomatic software for whole-body tumor burden assessment in prostate cancer using68Ga-PSMA11 PET/CT",
        "Deep neural network for automatic characterization of lesions on 68Ga-PSMA-11 PET/CT",
        "18F-FDG PET/CT uptake classification in lymphoma and lung cancer by using deep convolutional neural networks",
        "From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors",
        "Validation of a multifocal segmentation method for measuring metabolic tumor volume in Hodgkin lymphoma",
        "Time to prepare for risk adaptation in lymphoma by standardizing measurement of metabolic tumor burden",
        "FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0",
        "Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET",
        "The first MICCAI challenge on PET tumor segmentation",
        "Comparison of 11 automated PET segmentation methods in lymphoma",
        "Tumor segmentation and feature extraction from whole-body FDG-PET/CT using cascaded 2D and 3D convolutional neural networks",
        "Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network",
        "Metabolic tumour volume from PSMA PET/CT scans of prostate cancer patients during chemotherapy\u2014do different software solutions deliver comparable results?"
    ],
    "affiliation": [
        {
            "affiliation-city": "Munich",
            "@id": "60019722",
            "affilname": "Technische Universit\u00e4t M\u00fcnchen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019722",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Munich",
            "@id": "60117640",
            "affilname": "TUM Fakult\u00e4t f\u00fcr Medizin",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60117640",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "New York",
            "@id": "60084261",
            "affilname": "Siemens USA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60084261",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Munich",
            "@id": "60028673",
            "affilname": "Siemens AG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028673",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "European Union\u2019s Horizon 2020"
    ]
}